EPO published DexCom's patent application EP4634929A1 for a method of providing insight notifications on display devices related to analyte data, specifically glucose monitoring. The patent covers technology enabling real-time glucose monitoring systems to deliver insight notifications to patients. The designated states include all EU member states plus AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

This patent publication does not impose regulatory obligations on manufacturers or healthcare providers. It represents intellectual property protection for DexCom's technology. Competitors developing similar glucose monitoring systems should review the patent claims to assess potential licensing requirements or design-around needs. No compliance deadlines or penalties are associated with this publication.